Myriad Genetics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this afternoon, Myriad Genetics. (Operator Instructions)
And with that, let me turn it over to Paul.
Well, thank you, Tycho. Very much appreciate the opportunity to be here and really our 25-year relationship with JPMorgan.
Before we begin, I want to remind everyone that we'll be making certain forward-looking statements during the course of the presentation and referring to certain non-GAAP financial measures, and we encourage you to visit our website for additional information about the company, including our public filings.
So important to begin and emphasize the commitment that we have to being part of a health care system that we see as becoming increasingly patient centered and focused on wellness, prevention and engaging patients and providers with better tools
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
